International Biotechnology Trust’s Zai Lab ZLAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$1.92M Hold
78,958
0.65% 42
2023
Q2
$2.19M Hold
78,958
0.67% 35
2023
Q1
$2.63M Hold
78,958
0.73% 35
2022
Q4
$2.42M Hold
78,958
0.75% 32
2022
Q3
$2.69M Buy
78,958
+76,222
+2,786% +$3.26M 0.86% 36
2022
Q2
$79K Sell
2,736
-76,222
-97% -$2.69M 0.82% 30
2022
Q1
$17M Buy
78,958
+40,000
+103% +$1.93M 3.82% 10
2021
Q4
$2.45M Hold
38,958
0.55% 40
2021
Q3
$4.1M Buy
38,958
+26,158
+204% +$3.76M 0.99% 29
2021
Q2
$2.26M Buy
+12,800
New +$2.06M 0.6% 37

Other funds holding ZLAB

International Biotechnology Trust's ZLAB Position: Q3 2023 in Review

International Biotechnology Trust held its Zai Lab (ZLAB) position steady in Q3 2023 at 78,958 shares worth $1.92M. The position accounts for 0.65% of the portfolio, ranked #42.

International Biotechnology Trust first reported a position in ZLAB in Q2 2021 and has held it in 10 quarters since. The position peaked at $17M in Q1 2022. 122 funds tracked by Wall St. Rank hold ZLAB as of Q3 2023.

  • International Biotechnology Trust held 78,958 shares of Zai Lab worth $1.92M as of Q3 2023.
  • International Biotechnology Trust left its Zai Lab share count unchanged in Q3 2023.
  • Zai Lab made up 0.65% of International Biotechnology Trust's portfolio in Q3 2023, its #42 holding.
  • International Biotechnology Trust first reported a position in Zai Lab in Q2 2021 and has held it in 10 quarters since.
  • International Biotechnology Trust's Zai Lab position peaked at $17M in Q1 2022.
  • 122 funds tracked by Wall St. Rank held Zai Lab as of Q3 2023.

Based on International Biotechnology Trust's 13F filing for Q3 2023, filed 14 Nov 2023.